Intrapartum care for women on full anticoagulation

International Journal of Obstetric Anesthesia

Volumn 12, Issue 3, 2003, Pages 188-192

  Akkad, A ^a   Oppenheimer, C ^a   Mushambi, M ^a   Pavord, S ^a  

^a LEICESTER ROYAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ANTICOAGULATION; ARTICLE; BIOAVAILABILITY; CASE REPORT; FEMALE; HEALTH CARE PLANNING; HUMAN; INTENSIVE CARE UNIT; INTRAPARTUM HEMORRHAGE; LABOR; PREGNANCY; RECURRENT DISEASE; RISK FACTOR; THROMBOEMBOLISM;

EID: 0037700833     PISSN: 0959289X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-289X(03)00002-5     Document Type: Article

References (20)

1. Department of Health and others. Why mothers die. Report on Confidential Enquiries into Maternal Deaths in the United Kingdom 1997-1999. London: TSO, 2001.
2. McColl M, Gamsay J E, Tait R C et al. Risk factors for pregnancy associated venous thromboembolism. Thromb Haemost 1997; 78: 1183-1188.
3. Management of venous thromboembolism in pregnancy. Green top guidelines, Royal College of Obstetricians and Gynaecologists, London: 2001.
4. Leizorovic A, Haugh M C, Chapuis F R et al. Low molecular weight heparin in prevention of perioperative thrombosis. BMJ 1992; 305: 913-920.
5. Warkentin T E, Levine M N, Hish J et al. Heparin induced thrombocytopenia in patients treated with low molecular weight heparin or unfractioned heparin. N Engl J Med 1995; 332: 1330-1335.
6. Monreal M, Lafoz E, Olive A et al. Comparison of subcutaneous unfractioned heparin with low molecular weight heparin (Dalteparin) in patients with venous thromboembolism and contraindication for coumarin. Thromb Haemost 1994; 71: 7-11.
7. Omri A, Delaloye J F, Anderson H, Bachman F. Low molecular weight heparin Novo (LHN-1) does not cross the placenta during the second trimester of pregnancy. Thromb Haemost 1989; 61: 55-56.
8. Hirsh J. Low molecular weight heparin. Thromb Haemost 1993; 70: 204-207.
9. Haemostasis and thrombosis task force. Guidelines on oral anticoagulation; 3rd ed. Br J Haematol 1998; 101: 374-387.
10. Nelson-Piercy C, Letsky E A, de Swiet M. Low molecular weight heparin for obstetric thromboprophylaxis: experience of 69 pregnancies in 61 women at high risk. Am J Obstet Gynecol 1997; 176: 1062-1068.
11. Samama M, Berard P, Bonnardot J P et al. Low molecular weight heparin compared with unfractioned heparin in prevention of postoperative thrombosis. Br J Surg 1988; 75: 128-131.
12. Rowlands S, Lahoud R, Hertzberg M, Nicholl M. Thromboembolism treated with low molecular weight heparin in a pregnancy complicated by major placenta praevia: a case report. J Obstet Gyneacol Res 1997; 23: 205-208.
13. Combs C A, Murphy E L, Laros R K. Factors associated with postpartum haemorrhage with vaginal birth. Obstet Gynecol 1991; 77: 69-76.
14. Chamberlain G, Wright A, Steer P. Pain and its relief in childbirth. The results of the National survey conducted by the National Birthday Trust. London: Churchill Livingstone, 1993.
15. Loo C C, Dahlgren G, Irestedt L. Neurological complications of obstetric regional anaesthesia. International Journal of Obstetric Anesthesia 2000; 9: 99-124.
16. Hodnett E. Continuity of caregivers for care during pregnancy and childbirth. The Cochrane Database of Systematic Reviews, 2001.
17. Rayburn W F, Smith C V, Parriot J E, Woods R E. Randomized comparison of meperidine and fentanyl during labor. Obstet Gynecol 1989; 74: 604-606.
18. Thurlow J A, Laxton C H, Dick A, Waterhouse P. Comparison of patient controlled analgesia (PCA) using remifentanil with intramuscular pethidine for pain relief in labour. International Journal of Obstetric Anesthesia 2000; 9: 200.
19. Blair J M, Hill D A, Fee J P H. Patient controlled analgesia for labour using remifentanil: A feasibility study. Br J Anaesth 2001; 87: 415-420.
20. Thurlow J A, Laxton C H, Dick A, Waterhouse P, Sherman L, Goodman N W. Remifentanil by patient-controlled analgesia compared with intramuscular meperidine for pain relief in labour. Br J Anaesth 2002; 88: 374-378.